vs
CNO Financial Group, Inc.（CNO）与Healthpeak Properties（DOC）财务数据对比。点击上方公司名可切换其他公司
CNO Financial Group, Inc.的季度营收约是Healthpeak Properties的1.6倍（$1.1B vs $719.4M），Healthpeak Properties净利率更高（73.2% vs 8.8%，领先64.4%），CNO Financial Group, Inc.同比增速更快（4.2% vs 3.1%），过去两年Healthpeak Properties的营收复合增速更高（8.9% vs -0.6%）
CNO金融集团是总部位于美国印第安纳州卡梅尔的金融服务控股公司，前身为康塞科公司。集团旗下保险子公司为美国超400万客户提供人寿保险、年金和补充健康保险产品，通过独立代理人、专属代理人，以及电视广告、直邮等直销触达用户。
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金，核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建，总部设在科罗拉多州丹佛市，在尔湾、纳什维尔、旧金山均设有办事处，截至2019年12月31日共持有617处物业的权益。
CNO vs DOC — 直观对比
营收规模更大
CNO
是对方的1.6倍
$719.4M
营收增速更快
CNO
高出1.1%
3.1%
净利率更高
DOC
高出64.4%
8.8%
两年增速更快
DOC
近两年复合增速
-0.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $719.4M |
| 净利润 | $100.7M | $114.0M |
| 毛利率 | — | — |
| 营业利润率 | 15.2% | 17.4% |
| 净利率 | 8.8% | 73.2% |
| 营收同比 | 4.2% | 3.1% |
| 净利润同比 | -39.4% | 2406.4% |
| 每股收益（稀释后） | $1.02 | $0.16 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CNODOC
| Q4 25 | $1.1B | $719.4M | ||
| Q3 25 | $1.2B | $705.9M | ||
| Q2 25 | $1.2B | $694.3M | ||
| Q1 25 | $1.0B | $702.9M | ||
| Q4 24 | $1.1B | $698.0M | ||
| Q3 24 | $1.1B | $700.4M | ||
| Q2 24 | $1.1B | $695.5M | ||
| Q1 24 | $1.2B | $606.6M |
净利润CNODOC
| Q4 25 | $100.7M | $114.0M | ||
| Q3 25 | $23.1M | $-117.1M | ||
| Q2 25 | $91.8M | $31.7M | ||
| Q1 25 | $13.7M | $42.8M | ||
| Q4 24 | $166.1M | $4.5M | ||
| Q3 24 | $9.3M | $85.9M | ||
| Q2 24 | $116.3M | $146.0M | ||
| Q1 24 | $112.3M | $6.7M |
毛利率CNODOC
| Q4 25 | — | — | ||
| Q3 25 | — | 58.6% | ||
| Q2 25 | — | 60.2% | ||
| Q1 25 | — | 61.1% | ||
| Q4 24 | — | 60.3% | ||
| Q3 24 | — | 60.0% | ||
| Q2 24 | — | 60.6% | ||
| Q1 24 | — | 59.8% |
营业利润率CNODOC
| Q4 25 | 15.2% | 17.4% | ||
| Q3 25 | 13.7% | 9.2% | ||
| Q2 25 | 9.8% | 5.7% | ||
| Q1 25 | 10.4% | 7.7% | ||
| Q4 24 | 15.8% | -2.2% | ||
| Q3 24 | 13.6% | 14.1% | ||
| Q2 24 | 13.9% | 22.3% | ||
| Q1 24 | 6.5% | 3.7% |
净利率CNODOC
| Q4 25 | 8.8% | 73.2% | ||
| Q3 25 | 1.9% | -16.6% | ||
| Q2 25 | 8.0% | 4.6% | ||
| Q1 25 | 1.4% | 6.1% | ||
| Q4 24 | 15.1% | 0.7% | ||
| Q3 24 | 0.8% | 12.3% | ||
| Q2 24 | 10.9% | 21.0% | ||
| Q1 24 | 9.7% | 1.1% |
每股收益（稀释后）CNODOC
| Q4 25 | $1.02 | $0.16 | ||
| Q3 25 | $0.24 | $-0.17 | ||
| Q2 25 | $0.91 | $0.05 | ||
| Q1 25 | $0.13 | $0.06 | ||
| Q4 24 | $1.58 | $0.02 | ||
| Q3 24 | $0.09 | $0.12 | ||
| Q2 24 | $1.06 | $0.21 | ||
| Q1 24 | $1.01 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $467.5M |
| 总债务越低越好 | — | $9.8B |
| 股东权益账面价值 | $2.6B | $7.5B |
| 总资产 | $38.8B | $20.3B |
| 负债/权益比越低杠杆越低 | — | 1.31× |
8季度趋势，按日历期对齐
现金及短期投资CNODOC
| Q4 25 | — | $467.5M | ||
| Q3 25 | — | $91.0M | ||
| Q2 25 | — | $89.4M | ||
| Q1 25 | — | $70.6M | ||
| Q4 24 | — | $119.8M | ||
| Q3 24 | — | $180.4M | ||
| Q2 24 | — | $106.9M | ||
| Q1 24 | — | $101.8M |
总债务CNODOC
| Q4 25 | — | $9.8B | ||
| Q3 25 | — | $9.1B | ||
| Q2 25 | — | $9.0B | ||
| Q1 25 | — | $8.9B | ||
| Q4 24 | — | $8.7B | ||
| Q3 24 | — | $8.6B | ||
| Q2 24 | — | $8.6B | ||
| Q1 24 | — | $8.8B |
股东权益CNODOC
| Q4 25 | $2.6B | $7.5B | ||
| Q3 25 | $2.6B | $7.6B | ||
| Q2 25 | $2.5B | $7.9B | ||
| Q1 25 | $2.5B | $8.2B | ||
| Q4 24 | $2.5B | $8.4B | ||
| Q3 24 | $2.7B | $8.6B | ||
| Q2 24 | $2.4B | $8.8B | ||
| Q1 24 | $2.4B | $8.9B |
总资产CNODOC
| Q4 25 | $38.8B | $20.3B | ||
| Q3 25 | $38.3B | $19.6B | ||
| Q2 25 | $37.3B | $19.8B | ||
| Q1 25 | $37.4B | $19.8B | ||
| Q4 24 | $37.9B | $19.9B | ||
| Q3 24 | $37.6B | $20.0B | ||
| Q2 24 | $36.3B | $20.2B | ||
| Q1 24 | $34.9B | $20.5B |
负债/权益比CNODOC
| Q4 25 | — | 1.31× | ||
| Q3 25 | — | 1.20× | ||
| Q2 25 | — | 1.14× | ||
| Q1 25 | — | 1.08× | ||
| Q4 24 | — | 1.04× | ||
| Q3 24 | — | 1.00× | ||
| Q2 24 | — | 0.98× | ||
| Q1 24 | — | 0.99× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $195.7M | $1.3B |
| 自由现金流经营现金流 - 资本支出 | — | $357.0M |
| 自由现金流率自由现金流/营收 | — | 49.6% |
| 资本支出强度资本支出/营收 | — | 124.4% |
| 现金转化率经营现金流/净利润 | 1.94× | 10.99× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CNODOC
| Q4 25 | $195.7M | $1.3B | ||
| Q3 25 | $197.8M | $315.0M | ||
| Q2 25 | $145.5M | $363.5M | ||
| Q1 25 | $136.7M | $279.4M | ||
| Q4 24 | $191.0M | $1.1B | ||
| Q3 24 | $231.2M | $318.2M | ||
| Q2 24 | $110.9M | $316.2M | ||
| Q1 24 | $94.6M | $152.6M |
自由现金流CNODOC
| Q4 25 | — | $357.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $333.7M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率CNODOC
| Q4 25 | — | 49.6% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 47.8% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度CNODOC
| Q4 25 | — | 124.4% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 105.6% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率CNODOC
| Q4 25 | 1.94× | 10.99× | ||
| Q3 25 | 8.56× | — | ||
| Q2 25 | 1.58× | 11.48× | ||
| Q1 25 | 9.98× | 6.52× | ||
| Q4 24 | 1.15× | 235.43× | ||
| Q3 24 | 24.86× | 3.71× | ||
| Q2 24 | 0.95× | 2.17× | ||
| Q1 24 | 0.84× | 22.85× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CNO
| Health Insurance Product Line | $496.4M | 43% |
| Life Insurance Segment | $268.8M | 24% |
| Other | $207.2M | 18% |
| Life And Annuity Insurance Product Line | $170.7M | 15% |
DOC
暂无分部数据
